Browsing publications by Dr Jane Armstrong

Newcastle AuthorsTitleYearFull text
Dr David Hill
Dr Jane Armstrong
Professor Penny Lovat
A novel fully-humanised 3D skin equivalent to model early melanoma invasion2015
Dr Jane Armstrong
Dr David Hill
Christopher McKee
Maria Anagnostou
Fiyinfoluwa Babatunde
et al.
Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death2015
Dr Robert Ellis
Jonathan Lumsdon
Dr Nigel Kirkham
Dr Jane Armstrong
Professor Penny Lovat
et al.
Prognostic Impact of p62 Expression in Cutaneous Malignant Melanoma2014
Professor Mark Birch-Machin
Dr Robert Ellis
Dr Jane Armstrong
Professor Penny Lovat
Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy2013
Dr Graeme O'Boyle
Isabella Swidenbank
Dr Helen Marshall
Catriona Barker
Dr Jane Armstrong
et al.
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD110702013
Dr Robert Ellis
Dr Stamatina Verykiou
Jonathan Lumsdon
Dr Jane Armstrong
Dr Nigel Kirkham
et al.
Peri-tumoural expression of pro-autophagic Ambra-1 as a prognostic biomarker for melanoma2013
Dr Caroline Bridgens
Dr Gareth Veal
Dr Christopher Redfern
Dr Jane Armstrong
Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenylamino)phenyl)propyl scaffold2012
Dr Robert Ellis
Dr Jane Armstrong
Dr Nigel Kirkham
Professor Penny Lovat
p62 as a biomarker of malignant melanoma2012
Raymond Ellis
Dr Jane Armstrong
Dr Nigel Kirkham
Professor Penny Lovat
p62: a novel diagnostic and prognostic biomarker of malignant melanoma2012
Dr Caroline Bridgens
Dr Gareth Veal
Dr Christopher Redfern
Dr Jane Armstrong
Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates2012
12345